Enveda Biosciences News

Enveda raises $311M Series E at $2B valuation to advance nature-derived AI drug discovery.

Enveda, a biotech startup that mines plants and microbes for drug candidates using AI, closed a $311 million Series E led by Catalio Capital Management, with participation from Iconiq and others. The...